The device could one day be used for longer durations inside the body and used to power cells cells that target chronic diseases as well.
Ignatiev/iStock.
In 2021, the research team earned a $33 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop an implantable “living pharmacy” to control the sleep and wake cycles inside the body. In this approach, researchers implant living cells inside the body that produce the necessary therapeutics, freeing the individual from taking medicines.
Comments are closed.